BACKGROUND: Neuromyelitis optica spectrum disorder (NMOSD) is a rare autoimmune disease characterized by unpredictable attacks of the optic nerves and spinal cord that cause neurologic deficits, including weakness, numbness, bowel/bladder dysfunction, and pain and reduced vision and can ultimately lead to blindness and paralysis. We assessed the effects of NMOSD on quality of life. METHODS: Adult patients with NMOSD treated at a US academic neurology clinic completed the EQ-5D and several other measures of functional status and quality of life. The EQ-5D scores and correlations across measures were evaluated, and scores were compared with those of patients with multiple sclerosis and US norms. RESULTS: Twenty-one patients (90% women; mean age, 42.8 years; mean disease duration, 8.2 years) were included. The mean EQ-5D score was 0.74. Most patients reported at least some problems with mobility, pain/discomfort, usual activities, and/or anxiety/depression. Greater proportions of patients reported moderate or severe problems with mobility and pain/discomfort than they did with self-care, usual activities, or anxiety/depression. In a multivariate model, only the Brief Pain Inventory was a significant independent predictor of overall EQ-5D score. CONCLUSIONS: Neuromyelitis optica spectrum disorder has a substantial effect on multiple domains of quality of life. Pain seems to be among the primary drivers of the EQ-5D scores in NMOSD.
BACKGROUND: Neuromyelitis optica spectrum disorder (NMOSD) is a rare autoimmune disease characterized by unpredictable attacks of the optic nerves and spinal cord that cause neurologic deficits, including weakness, numbness, bowel/bladder dysfunction, and pain and reduced vision and can ultimately lead to blindness and paralysis. We assessed the effects of NMOSD on quality of life. METHODS: Adult patients with NMOSD treated at a US academic neurology clinic completed the EQ-5D and several other measures of functional status and quality of life. The EQ-5D scores and correlations across measures were evaluated, and scores were compared with those of patients with multiple sclerosis and US norms. RESULTS: Twenty-one patients (90% women; mean age, 42.8 years; mean disease duration, 8.2 years) were included. The mean EQ-5D score was 0.74. Most patients reported at least some problems with mobility, pain/discomfort, usual activities, and/or anxiety/depression. Greater proportions of patients reported moderate or severe problems with mobility and pain/discomfort than they did with self-care, usual activities, or anxiety/depression. In a multivariate model, only the Brief Pain Inventory was a significant independent predictor of overall EQ-5D score. CONCLUSIONS: Neuromyelitis optica spectrum disorder has a substantial effect on multiple domains of quality of life. Pain seems to be among the primary drivers of the EQ-5D scores in NMOSD.
Entities:
Keywords:
EQ-5D; Multiple sclerosis (MS); Neuromyelitis optica spectrum disorder; Pain; Quality of life
Authors: J-B Chanson; H Zéphir; N Collongues; O Outteryck; F Blanc; M Fleury; P Vermersch; J de Seze Journal: Eur J Neurol Date: 2010-11-18 Impact factor: 6.089
Authors: J A Cabrera-Gómez; M Bonnan; A González-Quevedo; A Saiz-Hinarejos; R Marignier; S Olindo; F Graus; D Smadja; H Merle; L Thomas; A Gómez-García; P Cabre Journal: Mult Scler Date: 2009-06-04 Impact factor: 6.312
Authors: Andrew McKeon; James P Fryer; Metha Apiwattanakul; Vanda A Lennon; Shannon R Hinson; Thomas J Kryzer; Claudia F Lucchinetti; Brian G Weinshenker; Dean M Wingerchuk; Elizabeth A Shuster; Sean J Pittock Journal: Arch Neurol Date: 2009-09
Authors: Maureen A Mealy; Sharon L Kozachik; Lawrence J Cook; Lauren Totonis; Ruth Andrea Salazar; Jerilyn K Allen; Marie T Nolan; Thomas J Smith; Michael Levy Journal: Neurology Date: 2020-04-08 Impact factor: 9.910
Authors: Martin W Hümmert; Louisa M Schöppe; Judith Bellmann-Strobl; Nadja Siebert; Friedemann Paul; Ankelien Duchow; Hannah Pellkofer; Tania Kümpfel; Joachim Havla; Sven Jarius; Brigitte Wildemann; Achim Berthele; Florian Then Bergh; Marc Pawlitzki; Luisa Klotz; Ingo Kleiter; Martin Stangel; Stefan Gingele; Martin S Weber; Juergen H Faiss; Refik Pul; Annette Walter; Uwe K Zettl; Makbule Senel; Jan-Patrick Stellmann; Vivien Häußler; Kerstin Hellwig; Ilya Ayzenberg; Orhan Aktas; Marius Ringelstein; Olivia Schreiber-Katz; Corinna Trebst Journal: Neurology Date: 2022-01-26 Impact factor: 9.910
Authors: Andrea Salazar-Camelo; Naveen George; Hesham Abboud; Sarah M Planchon; Marcelo Matiello; Maureen A Mealy; Andrew Goodman Journal: J Neurol Date: 2021-09-05 Impact factor: 4.849